体外冲击波疗法治疗性交痛：一项前瞻性、随机、双盲、安慰剂对照研究。
Extracorporeal shock wave therapy for treating dyspareunia: A prospective, randomized, double-blind, placebo-controlled study.
机构信息
Department of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University, Budinova 2, 18000 Prague, Czech Republic.
Sports Motoric Laboratory, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic.
出版信息
Ann Phys Rehabil Med. 2021 Nov;64(6):101545. doi: 10.1016/j.rehab.2021.101545. Epub 2021 Jul 27.
BACKGROUND
Dyspareunia is a genital pain during or after penile-vaginal sexual intercourse. It is a painful spasm of the pelvic muscles that partly or entirely disables vaginal penetration.
OBJECTIVES
We examined the effect of extracorporeal shock wave therapy (ESWT) on idiopathic non-organic dyspareunia in women. A prospective, randomized, double-blind, placebo-controlled study was conducted.
METHODS
The study included 62 women who reported dyspareunia. Patients in the treatment and placebo groups received ESWT perineally weekly for 4 consecutive weeks; placebo patients received placebo stand-off treatment. The grade of dyspareunia was estimated by using the Marinoff Dyspareunia Scale and subjective pain intensity on a visual analog scale (VAS) before and after treatment. Follow-ups were conducted 1, 4 and 12 weeks after the final ESWT session.
RESULTS
The study included 61 women. The treatment but not placebo group differed by the Marinoff Dyspareunia Scale and VAS. Differences before and after treatment within groups were all P<0.001 and between groups, P<0.001. Pain reduction was always>30%. The effect sizes were both large: Marinoff 0.825 and VAS 0.883.
CONCLUSIONS
ESWT significantly reduced subjective pain in our women treated for dyspareunia.
背景
性交疼痛是指在阴茎进入阴道或性交后出现的生殖器疼痛。它是一种骨盆肌肉的疼痛性痉挛，部分或完全使阴道无法插入。
目的
我们研究了体外冲击波疗法（ESWT）对女性特发性非器质性性交疼痛的影响。进行了一项前瞻性、随机、双盲、安慰剂对照研究。
方法
该研究纳入了 62 名报告性交疼痛的女性。治疗组和安慰剂组患者每周经会阴接受 ESWT 治疗 4 周，连续 4 周；安慰剂组患者接受安慰剂离石治疗。采用 Marinoff 性交疼痛量表和视觉模拟量表（VAS）评估性交疼痛程度，在治疗前后进行评估。在最后一次 ESWT 治疗后 1、4 和 12 周进行随访。
结果
该研究纳入了 61 名女性。只有治疗组而非安慰剂组在 Marinoff 性交疼痛量表和 VAS 上存在差异。组内治疗前后的差异均为 P<0.001，组间差异也为 P<0.001。疼痛缓解率始终>30%。效应大小均较大：Marinoff 为 0.825，VAS 为 0.883。
结论
ESWT 可显著减轻我们治疗的性交疼痛女性的主观疼痛。
Zotero 插件